Bumper Offer - Urjas oil Just @ Rs. 1
Atorvastatin + Fenofibrate + Ezetimibe is an allopathic medicine The correct dosage of Atorvastatin + Fenofibrate + Ezetimibe depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Atorvastatin + Fenofibrate + Ezetimibe is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Atorvastatin + Fenofibrate + Ezetimibe is used -
Severe
Moderate
Mild
Common
Is the use of Atorvastatin + Fenofibrate + Ezetimibe safe for pregnant women?
It is not known what effect Atorvastatin + Fenofibrate + Ezetimibe will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Atorvastatin + Fenofibrate + Ezetimibe safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Atorvastatin + Fenofibrate + Ezetimibe. Immediately discontinue Atorvastatin + Fenofibrate + Ezetimibe if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Kidneys?
Atorvastatin + Fenofibrate + Ezetimibe may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Liver?
You may experience side effects on your liver after taking Atorvastatin + Fenofibrate + Ezetimibe. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Atorvastatin + Fenofibrate + Ezetimibe on the Heart?
Very few cases of side effects of Atorvastatin + Fenofibrate + Ezetimibe on the heart have been reported.
Atorvastatin + Fenofibrate + Ezetimibe should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Atorvastatin + Fenofibrate + Ezetimibe unless your doctor advises you to do so -
Is this Atorvastatin + Fenofibrate + Ezetimibe habit forming or addictive?
Forming a habit of Atorvastatin + Fenofibrate + Ezetimibe has not been reported.
Interaction between Food and Atorvastatin + Fenofibrate + Ezetimibe
Taking Atorvastatin + Fenofibrate + Ezetimibe with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Atorvastatin + Fenofibrate + Ezetimibe
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Atorvastatin + Fenofibrate + Ezetimibe.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zetia® (ezetimibe)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 641
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 545-546
